Takeda
1,285
105
165
887
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 30/100
14.2%
182 terminated/withdrawn out of 1285 trials
83.0%
-3.5% vs industry average
36%
467 trials in Phase 3/4
73%
644 of 887 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1285)
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
Role: lead
Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
Role: collaborator
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Role: lead
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Role: lead
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Role: collaborator
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Role: lead
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Role: lead
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
Role: lead
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Role: lead
A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries
Role: lead
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
Role: lead
A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia
Role: lead
A Study of Prucalopride in Breastfeeding Women With Constipation
Role: lead
A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt
Role: lead
A Study of Surgical Interventions in Fistulizing Conditions
Role: lead
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Role: lead
Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
Role: collaborator
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
Role: lead
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Role: lead
A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea
Role: lead